Wells Fargo’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $252K | Buy |
49,217
+26,422
| +116% | +$135K | ﹤0.01% | 4250 |
|
2025
Q1 | $31.2K | Buy |
22,795
+503
| +2% | +$689 | ﹤0.01% | 5100 |
|
2024
Q4 | $68.9K | Buy |
22,292
+7,599
| +52% | +$23.5K | ﹤0.01% | 4893 |
|
2024
Q3 | $113K | Sell |
14,693
-581
| -4% | -$4.47K | ﹤0.01% | 4546 |
|
2024
Q2 | $131K | Sell |
15,274
-539
| -3% | -$4.63K | ﹤0.01% | 4421 |
|
2024
Q1 | $126K | Buy |
15,813
+2,025
| +15% | +$16.1K | ﹤0.01% | 4393 |
|
2023
Q4 | $137K | Buy |
13,788
+2,717
| +25% | +$26.9K | ﹤0.01% | 4315 |
|
2023
Q3 | $125K | Sell |
11,071
-5,928
| -35% | -$66.7K | ﹤0.01% | 4322 |
|
2023
Q2 | $56.4K | Buy |
16,999
+8,731
| +106% | +$29K | ﹤0.01% | 5101 |
|
2023
Q1 | $32.7K | Buy |
+8,268
| New | +$32.7K | ﹤0.01% | 5095 |
|
2022
Q4 | – | Sell |
-96
| Closed | – | – | 7370 |
|
2022
Q3 | $0 | Sell |
96
-613
| -86% | – | ﹤0.01% | 7028 |
|
2022
Q2 | $3K | Buy |
709
+316
| +80% | +$1.34K | ﹤0.01% | 5931 |
|
2022
Q1 | $3K | Buy |
393
+1
| +0.3% | +$8 | ﹤0.01% | 6247 |
|
2021
Q4 | $4K | Buy |
392
+1
| +0.3% | +$10 | ﹤0.01% | 6210 |
|
2021
Q3 | $5K | Buy |
+391
| New | +$5K | ﹤0.01% | 6054 |
|
2021
Q1 | – | Sell |
-8,568
| Closed | -$98K | – | 6948 |
|
2020
Q4 | $98K | Buy |
+8,568
| New | +$98K | ﹤0.01% | 5202 |
|